The Diagnosis
Stage IV. Age 44.
Bryce was diagnosed with aggressive stage IV prostate cancer at the age of 44. When the standard treatment options failed, Bryce turned to genomic sequencing — which empowered his medical team to identify the molecular drivers behind his cancer and tailor treatments and clinical trials to his unique profile.
"The driver of my cancer was hidden in my DNA. I asked my doctors to 'Sequence Me.' The insights from genomic sequencing opened new doors and saved my life. Fight cancer differently — with data."
— Bryce Olson
His message to others was clear, and he repeated it everywhere he went — at TEDx events, on stages from Nantucket to Zurich, in conversations with strangers in oncology waiting rooms:
"You can do this, too."
— Bryce Olson
The Legacy
He Outlived The Prognosis. The Movement Outlives Him.
Although Bryce's nine-year cancer experience came to an end in July 2023, he exceeded his initial prognosis by fivefold — credited to a series of cutting-edge therapies made possible through close collaboration with Dr. Rana McKay at UCSD and his medical teams along the way.
The legacy of Bryce's resilience and advocacy continues to inspire, driving efforts to make genomic testing more accessible to those in need. His family and friends — now organized as the Motley Crew board of Sequence Me Now — remain dedicated to continuing his mission: to raise awareness, demand sequencing, and inspire those diagnosed with cancer to advocate for personalized, data-driven care.
Devona OlsonBryce’s daughter, on the movement he left behind.
